This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-celgene.jpg" NAME"This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene" ALT"This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene"February 20, 2017By…

Continue ReadingThis Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene

Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-cocoon-biotech-ailis-tweed-kent.jpg" NAME"Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech" ALT"Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech"February 17, 2017By Alex Keown,…

Continue ReadingWoman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech

SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-sage-therapeutics-jeff-jonas.jpg" NAME"SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity" ALT"SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity"February 17, 2017By…

Continue ReadingSAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity

After Merck & Co. & Eli Lilly Alzheimer???s Failures, A Look at 7 Companies Still on the Hunt

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"After Merck & Lilly Alzheimers Failures, A Look at 7 Companies Still on the Hunt" ALT"After Merck & Lilly Alzheimers Failures, A Look at 7 Companies Still on…

Continue ReadingAfter Merck & Co. & Eli Lilly Alzheimer???s Failures, A Look at 7 Companies Still on the Hunt